Catheter Precision Inc. (NYSE American: VTAK) is currently drawing attention. spotlight by “Cardiac Rhythm News” a trusted, independent news source worldwide located in London, United Kingdom, on Tuesday underscored the significance of Catheter Precision’s innovative strides in the cardiac treatment sector. Interest in companies advancing cardiac treatment is consistently high, especially when its VIVO™ 3D Mapping System secured reimbursement approval from England’s Specialized Services Devices Program (SSDP) at the National Health Service (NHS) in the United Kingdom.
VIVO™ 3D Mapping System’s revolutionary potential, is its non-invasive alternative to traditional methods that are often invasive, time-consuming, and not consistently successful. VIVO™ is employed before procedures commence, displaying a reduction in mapping time of up to 30% in clinical studies. This efficiency not only shortens procedure duration but also streamlines workflows.
It’s crucial to highlight that the SSDP was previously known as the HCTED (High-Cost Tariff Excluded Devices), and the inclusion paves the way for comprehensive reimbursement for the utilization of the VIVO™ 3D Mapping System. This inclusion is expected to enhance the accessibility of the product worldwide. Investors should note that this device represents a significant advancement in cardiovascular treatments, particularly in the early detection of cardiac arrhythmias before medical procedures.
Investors may find it opportune to monitor updates on “Cardiac Rhythm News” for further developments related to the VIVO™ 3D Mapping System. Notably, VTAK stock demonstrated a 9% gain in Tuesday’s trading session, accompanied by higher-than-average trading volume. This positive market response underscores the growing interest and confidence in Catheter Precision Inc.’s advancements in the cardiac treatment space. See complete news article: https://cardiacrhythmnews.com/catheter-precisions-vivo-3d-mapping-system-secures-reimbursement-in-nhs-englands-ssdp/
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com